Drops
Drops

Drops

Upcoming
IPT
Aging
$DROPS

Our Moon Drops for Skin Longevity serum optimizes the clinically proven Ferulic Acid + Vitamin C + Vitamin E winning combo using safe, high-purity actives. The combination of our Sun Drops UV filter enhances anti-aging skin protection and restoration with active development powered by inclusive decentralized trial protocols.

Community Sentiment

How do you feel about this ipt?

...
No trend data
Project

Market Overview

$198 Billion
Global skincare industry in 2025
3 Billion
Individuals affected by skin disease
83%
People globally believing that appearance is important for general wellbeing

Summary

Moon & Sun Drops pair proven Ferulic Acid with Vitamin C/E with an innovative UV filter. Our market-ready products will be sold DTC and validated by our AI-powered SkinScan app. Using DeSci approaches, we will iterate quickly via community trials, and build evidence-based products.

Problem

Skincare claims outpace evidence. Formulas vary in composition, purity, and delivery; sunscreens leave UVA spectrum gaps; and clinic imaging is costly. Consumers lack transparent, real-world proof across diverse skin types to guide purchase and care.

Impact

Open, token-incentivized trials can generate validated outcomes, de-risking purchases and accelerating R&D. Revenue funds new IP and products, and users own their data and steer roadmaps. The result will be measurable benefits, stronger trust, and a defensible evidence-led brand.

Future IP Directions

- Compositions & Methods: C+E+ferulic acid variants, formulation potency.

- Analytics & Tooling: SkinScan models, standardized capture protocols, trial code.

- Licensing & Spin-outs: royalty-sharing for DTC, partnerships, and SKUs.

- Governance IP: token-gated data access, commons stewardship, and reproducibility standards.

Jez Marston, PhD

Physician-scientist and entrepreneur with a PhD in Immunology and Computational Biology from Cornell University. Previous scientific training at Yale and the University of Cambridge. Extensive experience in cell biology, genetics, biopharma, drug development, life science investing across the United States, UK and EU with a focus on translational science and innovation in dermatology, skincare, and longevity.

Dongsinne Sohn

At the crossroads of health and Web3, Dongsinne is a French-Korean entrepreneur who has previously built a skincare company for children suffering from eczema (atopic dermatitis) and has managed major crypto events worldwide for a decade. She is now weaving skin, science, and community into a new paradigm for skin health, bridging cultures and technologies to imagine a future where innovation heals beyond boundaries.

Dr. Hongseok Kim

Korean board-certified dermatologist and MD, known on YouTube as “피부를 알려주는 남자 (Dr. DTS),” where he turns complex skin science into clear, evidence-based K-Beauty guidance. At DermaDAO, Dr. Kim connects cutting-edge dermatology, real-world clinic insights, and community-driven research to shape the future of decentralized skin health.

Hyeon Pyo Jhun

CEO and Lead Chemist of a top research-driven Korean cosmetics manufacturer, with over 40 years of expertise in high-performance skincare R&D and formulation. As DermaDAO’s chemist, Mr. Jhun oversees formulation integrity, scale-up, and quality systems—ensuring Moon and Sun Drops are grounded in rigorous science, ethical production, and globally trusted standards.

Q3 2025

Formulate and test CE Ferulic + UV filter serums “Moon x Sun Drops”

Q4 2025

Launch $DROPS and seed the CE Ferulic project treasury

Open a DTC storefront with a clinically validated CE ferulic formulation

Q1 2026

Release SkinScan to track skin metrics and product impact

Enroll the first SkinScan-tracked community trial for CE Ferulic + UV filter products

Q2 2026

Explore frontier actives (longevity ingredients, bioactive peptides) for new products

Q4 2026

Launch an expanded OTC longevity line targeting wrinkles, hydration, pigmentation, barrier repair

Tokenomics

10,000,000

Total Supply
Ignition Sale
10%
Wide Liquidity
22.5%
Concentrated Liquidity
15%
Team
10%
Treasury
15%
DermaDAO
20%
veBIO Airdrop
5%
Bio Protocol Call Option
2.5%
Ignition Sale (liquid)
Wide Liquidity
Concentrated Liquidity
veBIO Airdrop
Ignition Sale (vesting)
Treasury
Bio Protocol Call Option
Team
DermaDAO
Loading chart...
Community
Feed
...

Stay up to date

Get the latest community updates and find out about upcoming Drops developments